Inhibitor development in haemophilia.

Abstract

HaemophiliaVolume 23, Issue S1 p. 3-3 Foreword Inhibitor development in haemophilia F. Peyvandi, F. Peyvandi flora.peyvandi@unimi.it Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, ItalySearch for more papers by this authorM. Makris, M. Makris m.makris@sheffield.ac.uk Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, United KingdomSearch for more papers by this author F. Peyvandi, F. Peyvandi flora.peyvandi@unimi.it Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, ItalySearch for more papers by this authorM. Makris, M. Makris m.makris@sheffield.ac.uk Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, United KingdomSearch for more papers by this author First published: 19 December 2016 https://doi.org/10.1111/hae.13145Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume23, IssueS1Special Issue: New Findings on Inhibitor Development: from Registries to Clinical StudiesJanuary 2017Pages 3-3 RelatedInformation